Status:
ACTIVE_NOT_RECRUITING
Short Arm Human Centrifuge Therapeutic Training and Rehabilitation (GRACER1)
Lead Sponsor:
Greek Aerospace Medical Association and Space Research
Conditions:
Multiple Sclerosis
Stroke
Eligibility:
All Genders
17-90 years
Phase:
NA
Brief Summary
The study is a single blind randomized controlled trial (RCT) designed to examine the benefit of a short arm human centrifuge intervention program (SAHC) combined with exercise, compared to a standard...
Detailed Description
The patients will be randomly assigned to the short arm human centrifuge training (SAHC intervention), standard of care (SOC training) or a passive control. The SAHC intervention consists of 3 session...
Eligibility Criteria
Inclusion
- both male and female
- height less than 2 m,
- healthy or
- with gait disorder or
- impaired mobility from multiple sclerosis or
- stroke,
- chronic obstructive pulmonary disease (COPD) or
- elderly
Exclusion
- Neurological or psychiatric disorder,
- vertigo,
- nausea or
- chronic pain,
- participants with a height greater than 2 meters,
- participants with chronic use of substances or alcoholism,
- with recent (within 6 months) surgery,
- current arrhythmia,
- severe migraines,
- pregnancy,
- epilepsy,
- cholelithiasis or
- kidney stones,
- dehydration,
- recent wounds from surgery,
- recent fractures (unless recommended by a doctor),
- acute inflammation or
- pain and
- newly inserted metal pins or plates, newly implanted stents .
Key Trial Info
Start Date :
February 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT04369976
Start Date
February 1 2020
End Date
December 1 2025
Last Update
March 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Euromedica-Arogi Rehabilitation Center
Thessaloniki, FW, Greece, 54210